Inspire Medical Systems (INSP) Cash from Investing Activities (2017 - 2026)

Inspire Medical Systems has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$11.2 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$11.2 million, down 624.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.8 million (up 112.35% YoY), and the FY2025 annual result was $21.4 million, up 118.96% from the prior year.
• Cash from Investing Activities came in at -$11.2 million for Q1 2026 at Inspire Medical Systems, up from -$11.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $46.6 million in Q2 2025 to a low of -$151.7 million in Q4 2023.
• The 5-year median for Cash from Investing Activities is -$3.8 million (2022), against an average of -$24.5 million.
• Across the five-year window, Cash from Investing Activities plunged 5043.15% in 2023 and soared 728.51% in 2025, its largest moves.
• Inspire Medical Systems' Cash from Investing Activities stood at -$2.9 million in 2022, then slumped by 5043.15% to -$151.7 million in 2023, then surged by 102.48% to $3.8 million in 2024, then tumbled by 416.88% to -$11.9 million in 2025, then rose by 5.61% to -$11.2 million in 2026.
• The last three Cash from Investing Activities figures came in at -$11.2 million (Q1 2026), -$11.9 million (Q4 2025), and -$11.6 million (Q3 2025), per Business Quant data.